138 related articles for article (PubMed ID: 18211813)
1. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST.
Kurihara T; Yanagida A; Yokoi H; Koyata A; Matsuya T; Ogawa J; Okamura Y; Miyamoto D
Anal Biochem; 2008 Apr; 375(1):144-6. PubMed ID: 18211813
[TBL] [Abstract][Full Text] [Related]
2. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
[TBL] [Abstract][Full Text] [Related]
3. Multi-site, multi-country evaluation of analytical and operational performance of a low-mid volume chemiluminescent immunoassay analyzer.
De Keijzer MH; Perkins S; Motta V; Morelli D; Cristol JP; Dupuy AM; Hong Y; Watanabe S; Waerdt C; Grunewald RW
Clin Lab; 2009; 55(9-10):363-70. PubMed ID: 20099573
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of a new chemiluminescent cardiac troponin I assay.
Dasgupta A; Chow L; Nazareno L; Tso G; Datta P
J Clin Lab Anal; 2000; 14(5):224-9. PubMed ID: 11018801
[TBL] [Abstract][Full Text] [Related]
5. Analytical performances of the D-dimer assay for the Immulite 2000 automated immunoassay analyser.
Lippi G; Salvagno GL; Rossi L; Montagnana M; Franchini M; Guidi GC
Int J Lab Hematol; 2007 Dec; 29(6):415-20. PubMed ID: 17988295
[TBL] [Abstract][Full Text] [Related]
6. Fit-for-purpose evaluation of architect i1000SR immunoassay analyzer.
Rukhsana J; Perrotta PL; Okorodudu AO; Petersen JR; Mohammad AA
Clin Chim Acta; 2010 Jun; 411(11-12):798-801. PubMed ID: 20188084
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the ARCHITECT STAT troponin-I assay.
Hubl W; Demant T; Gladrow E
Clin Lab; 2005; 51(5-6):251-5. PubMed ID: 15991798
[TBL] [Abstract][Full Text] [Related]
8. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing.
Wu AH; Jaffe AS
Am Heart J; 2008 Feb; 155(2):208-14. PubMed ID: 18215588
[TBL] [Abstract][Full Text] [Related]
9. [Fluorescence polarization immunoassay and microparticle enzyme immunoassay].
Suguri M; Hirose N; Myoga A; Doss R; Tatsumi N
Rinsho Byori; 1996 Nov; 44(11):1072-5. PubMed ID: 8953938
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a third generation allergen-specific IgE assay on the continuous random access IMMULITE 2000 analyzer.
Li TM; Chuang T; Tse S; Hovanec-Burns D; El Shami AS
Ann Clin Lab Sci; 2004; 34(1):67-74. PubMed ID: 15038670
[TBL] [Abstract][Full Text] [Related]
11. [Access immunoassay system--troponin I and myocardial damage].
Yamanaka S; Sugiura T
Rinsho Byori; 2003 Jun; Suppl 126():84-9. PubMed ID: 12905946
[No Abstract] [Full Text] [Related]
12. Chemiluminometric enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor based on cross-flow chromatography.
Cho IH; Paek EH; Kim YK; Kim JH; Paek SH
Anal Chim Acta; 2009 Jan; 632(2):247-55. PubMed ID: 19110101
[TBL] [Abstract][Full Text] [Related]
13. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
Schmid RW; Lotz J; Schweigert R; Lackner K; Aimo G; Friese J; Rosiere T; Dickson D; Kenney D; Maine GT
Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Troponin I assay employing enhanced chemiluminescence technology.
Fairley O
Am Clin Lab; 2000 Apr; 19(3):18. PubMed ID: 11010586
[No Abstract] [Full Text] [Related]
15. [Present status and future of enzyme immunoassay--hormone].
Uchimura H
Nihon Rinsho; 1995 Sep; 53(9):2245-9. PubMed ID: 7474388
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 99th percentile value of a chemiluminescence enzyme immunoassay (CLEIA) for cTnI using the automated AIA-CL2400 platform.
Masotti S; Musetti V; Aloe R; Rizzardi S; Dittadi R; Carrozza C; Perrone M; Fasano T; de Santis A; Prontera C; Guiotto C; Clerico A
Clin Chim Acta; 2019 Sep; 496():45-47. PubMed ID: 31228415
[No Abstract] [Full Text] [Related]
17. The development of Luminomaster, a fully automated chemiluminescent enzyme immunoassay system.
Ikegami T; Yamamoto M; Sekiya K; Sato Y; Saito Y; Maeda M; Tsuji A
J Biolumin Chemilumin; 1995; 10(4):219-27. PubMed ID: 8533603
[TBL] [Abstract][Full Text] [Related]
18. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
Wilson SR; Sabatine MS; Braunwald E; Sloan S; Murphy SA; Morrow DA
Am Heart J; 2009 Sep; 158(3):386-91. PubMed ID: 19699861
[TBL] [Abstract][Full Text] [Related]
19. Development of a sensitive, rapid, biotin-streptavidin based chemiluminescent enzyme immunoassay for human thyroid stimulating hormone.
Lin Z; Wang X; Li ZJ; Ren SQ; Chen GN; Ying XT; Lin JM
Talanta; 2008 May; 75(4):965-72. PubMed ID: 18585170
[TBL] [Abstract][Full Text] [Related]
20. Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms.
Christenson RH; Azzazy HM
Clin Biochem; 2009 Feb; 42(3):150-7. PubMed ID: 18929551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
